1-7 of 7
Valeria Belsito Petrizzi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long Term Toxicity and Follow-up of Waldenstrom´s Macroglobulinemia Patients after Salvage Treatment with Fludarabine Cyclophosphamide Rituximab or Bendamustine and Rituximab

Alessandra Tedeschi, MD, Paola Picardi, MD, Maria Cecilia Goldaniga, MD, Gloria Margiotta Casaluci, MD, Giulia Benevolo, MD, Simone Ferrero, MD, Marzia Varettoni, MD, Claudia Baratè, MD, Guido Gini, MD, Carlo Visco, MD, Marina Motta, MD, Valeria Belsito Petrizzi, MD, Francesco Zaja, MD, Erica Ravelli, MD, Massimo Gentile, MD, Anna Maria Frustaci, MD, Lorella Orsucci, MD, Enrica Morra, MD, Gianluca Gaidano, Roberto Cairoli, MD
Journal: Blood
Blood (2015) 126 (23): 3958.
https://doi.org/10.1182/blood.V126.23.3958.3958
Published: 2015
Journal Articles

Bendamustine and Rituximab Combination Is Safe and Effective As Salvage Regimen in Waldenstrom's Macroglobulinemia

Alessandra Tedeschi, MD, Giulia Benevolo, MD, Gloria Casaluci Margiotta, MD, Simone Ferrero, MD, Paola Picardi, MD, Marzia Varettoni, MD, Claudia Baratè, MD, Marina Motta, MD, Guido Gini, MD, Maria Cecilia Goldaniga, MD, Carlo Visco, Francesco Zaja, Valeria Belsito Petrizzi, MD, Erika Ravelli, Massimo Gentile, MD, Marina Urbano, Silvia Franceschetti, Lorella Orsucci, MD, Annamaria Frustaci, Paola Riccomagno, MD, Paola Ghione, Gianluca Gaidano, MD, Umberto Vitolo, MD, Enrica Morra
Journal: Blood
Blood (2014) 124 (21): 3072.
https://doi.org/10.1182/blood.V124.21.3072.3072
Published: 2014
Journal Articles

Final Report of Bendamustine and Alemtuzumab (BEN CAM) Combination in Relapsed and Refractory Chronic Lymphocytic Leukemia.

Alessandra Tedeschi, MD, Davide Rossi, MD, Marta Coscia, MD, PhD, Eleonora Vismara, MD, Valeria Belsito Petrizzi, MD, Ester Orlandi, Nicola Cascavilla, Lydia Scarfò, MD, Marina Motta, MD, Candida Vitale, MD, Francesca Ricci, MD, Lorenzo De Paoli, MD, Alfonso Maria D'Arco, MD, Andrea Gallamini, MD, Gianluca Gaidano, MD, PhD, Enrica Morra, MD, Massimo Massaia, MD, Marco Montillo, MD
Journal: Blood
Blood (2012) 120 (21): 2898.
https://doi.org/10.1182/blood.V120.21.2898.2898
Published: 2012
Journal Articles

An open-label, pilot study of fludarabine, cyclophosphamide, and alemtuzumab in relapsed/refractory patients with B-cell chronic lymphocytic leukemia

Clinical Trials & Observations
Marco Montillo, Alessandra Tedeschi, Valeria Belsito Petrizzi, Francesca Ricci, Monica Crugnola, Mauro Spriano, Pierangelo Spedini, Fiorella Ilariucci, Lilj Uziel, Immacolata Attolico, Eleonora Vismara, Angelo De Blasio, Alfonso Zaccaria, Enrica Morra
Journal: Blood
Blood (2011) 118 (15): 4079–4085.
https://doi.org/10.1182/blood-2011-05-351833
Published: 2011
Journal Articles

Fludarabine, Cyclophosphamide, and Alemtuzumab (FCC) In Relapsed/Refractory Patients with B-Cell Chronic Lymphocytic Leukemia (CLL): Final Report of the Italian Study

Marco Montillo, MD, Alessandra Tedeschi, Francesca Ricci, Alfonso Zaccaria, Monica Crugnola, Mauro Spriano, PierAngelo Spedini, Fiorella Ilariucci, Lilj Uziel, Immacolata Attolico, Angelo De Blasio, Eleonora Vismara, Enrica Morra, Valeria Belsito Petrizzi
Journal: Blood
Blood (2010) 116 (21): 1384.
https://doi.org/10.1182/blood.V116.21.1384.1384
Published: 2010
Journal Articles

Safety and Efficacy of Bendamustine with or without Rituximab for the Treatment of Heavily Pretreated CLL and Lymphoma Patients. A Multicenter Retrospective Study.

Luigi Rigacci, Benedetta Puccini, Enrico Orciuolo, Alfonso D'Arco, Sergio Storti, Gianluca Gaidano, Roberto Freilone, Nicola Di Renzo, MD, Caterina Patti, MD, Alessandro Isidori, MD, PhD, Pier Luigi Zinzani, MD, Marco Gobbi, MD, Pellegrino Musto, MD, Anna Marina Liberati, MD, Andrea Carpaneto, Sergio Cortelazzo, Nicola Cascavilla, MD, Nadia Cecconi, Valeria Belsito Petrizzi, Giulio Giordano, MD, Silvia Franceschetti, Atto Billio, Alberto Bosi, MD
Journal: Blood
Blood (2009) 114 (22): 1662.
https://doi.org/10.1182/blood.V114.22.1662.1662
Published: 2009
Journal Articles

Combined Fludarabine, Cyclophosphamide, and Alemtuzumab (FCC), an Active Regimen for Treated Patients with Chronic Lymphocytic Leukemia (CLL).

Marco Montillo, MD, Sara Miqueleiz, MD, Alessandra Tedeschi, MD, Francesca Ricci, MD, Eleonora Vismara, MD, Denis Ciapanna, MD, Valeria Belsito Petrizzi, MD, Monica Crugnola, MD, Mauro Spriano, MD, Lilj Uziel, MD, Angelo De Blasio, MD, Pierangelo Spedini, PhD, Enrica Morra, MD
Journal: Blood
Blood (2007) 110 (11): 3133.
https://doi.org/10.1182/blood.V110.11.3133.3133
Published: 2007